Search:


Martha Nolte, M.D.
Nolte, M., Karam, J.H: Pancreatic Hormones & Antidiabetic Drugs.  Basic & Clinical Pharmacology, Ed. Bertram G. Katzung, 8th Edition. Lange/McGraw Hill 2004.

Gehi, A.,Webb, A., Nolte,M., Davis,J.:Case Report: Treatment of Systemic Lupus Erythematosus associated with Type B Insulin Resistance Syndrome with Cyclophosphamide and Mycophenolate Mofetil. Arthritis and Rheumatism 48:1067, 2003.

Rol, U., Turck, C.W., Gitelman, S.E., Rosenthal, S.M., Nolte, M.S., Masharani, U., Ziegler, A.G., Baekkeskov, S.: Peptide mapping and characterization of glycosylation patterns of the glima 38 antigen recognized by autoantibodies in Type I diabetes patients.  Diabetologia 43: 598, 2000.

Klonoff, D.L., Barrett, B.J., Nolte, M.S., Cohen, R.M., Wyderski, R.: Hypoglycemia Following Inadvertently and Advertently Unreported Sulfonylurea Overdosages.  Diabetes Care 18:563, 1995.

Nolte, M.S., “Insulin Therapy in Insulin Dependent (Type I) Diabetes Mellitus” in Endocrinology and Metabolism Clinics of North America.  June, 1992, p. 281 – 305.